Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Mural Oncology PLC has a consensus price target of $16 based on the ratings of 5 analysts. The high is $18 issued by HC Wainwright & Co. on November 14, 2024. The low is $13 issued by Morgan Stanley on April 4, 2024. The 3 most-recent analyst ratings were released by Jones Trading, HC Wainwright & Co., and HC Wainwright & Co. on January 27, 2025, November 14, 2024, and November 11, 2024, respectively. With an average price target of $17.33 between Jones Trading, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 362.22% upside for Mural Oncology PLC from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Mural Oncology (NASDAQ:MURA) was reported by Jones Trading on January 27, 2025. The analyst firm set a price target for $16.00 expecting MURA to rise to within 12 months (a possible 326.67% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Mural Oncology (NASDAQ:MURA) was provided by Jones Trading, and Mural Oncology initiated their buy rating.
There is no last upgrade for Mural Oncology
There is no last downgrade for Mural Oncology.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mural Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mural Oncology was filed on January 27, 2025 so you should expect the next rating to be made available sometime around January 27, 2026.
While ratings are subjective and will change, the latest Mural Oncology (MURA) rating was a initiated with a price target of $0.00 to $16.00. The current price Mural Oncology (MURA) is trading at is $3.75, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.